CAS NO: | 188125-42-0 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | Zolunicant (MM-110) is a potent inhibitor againstnicotinic α3β4 receptorswith anIC50of 0.90 μM to combat addiction. Zolunicant can decrease the self-administration of several addictive agents including morphine, cocaine, methamphetamine, nicotine, and ethanol in rat model. Zolunicant can be studied as a potential treatment for multiple forms of drug abuse[1]. Zolunicant also reveals a potent leishmanicide effect againstLeishmaniaamazonensis[2]. | ||||||||
IC50& Target | IC50: 0.90 μM (nicotinic α3β4 receptor)[1] | ||||||||
体外研究 (In Vitro) | Zolunicant (18-MC; 0.01-100 μM) shows an inhibitory activity against nicotinic α3β4 receptors with an IC50of 0.90 μM[1]. Cell Viability Assay[2]
| ||||||||
体内研究 (In Vivo) | Zolunicant (18-MC; Intravenous administration; 0-20 μg a day;14 days) decreases morphine self-administration by blocking α3β4 nicotinic receptors in the habenulo-interpeduncular pathway[3].
| ||||||||
分子量 | 368.47 | ||||||||
Formula | C22H28N2O3 | ||||||||
CAS 号 | 188125-42-0 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |